Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin Mills

Showing results (101-110 of 129) with videos related to

Pageof 13
Sort By:
Analytical Chemistry|November 6, 2015
Proteomic Discovery and Development of a Multiplexed Targeted MRM-LC-MS/MS Assay for Urine Biomarkers of Extracellular Matrix Disruption in Mucopolysaccharidoses I, II, and VIWendy E Heywood, Stephane Camuzeaux, Ivan Doykov, et al.
Brain, Behavior, and Immunity|December 13, 2025
Resistant starch improves Parkinson's disease symptoms through restructuring of the gut microbiome and modulating inflammationViacheslav A Petrov, Sebastian Schade, Cedric C Laczny, et al.
Scientific Reports|June 22, 2016
The embryological basis of subclinical hypertrophic cardiomyopathyGabriella Captur, Carolyn Y Ho, Saskia Schlossarek, et al.
JAMA Neurology|January 14, 2020
Ambroxol for the Treatment of Patients With Parkinson Disease With and Without Glucocerebrosidase Gene Mutations: A Nonrandomized, Noncontrolled TrialStephen Mullin, Laura Smith, Katherine Lee, et al.
International Journal of Molecular Sciences|January 21, 2022
Tissue Proteome of 2-Hydroxyacyl-CoA Lyase Deficient Mice Reveals Peroxisome Proliferation and Activation of ω-OxidationYoussef Khalil, Sara Carrino, Fujun Lin, et al.
Molecular Neurodegeneration|February 25, 2016
Erratum to: Identification of novel CSF biomarkers for neurodegeneration and their validation by a high-throughput multiplexed targeted proteomic assayWendy E Heywood, Daniela Galimberti, Emily Bliss, et al.
Iscience|December 11, 2020
An <i>In Vitro</i> Whole-Organ Liver Engineering for Testing of Genetic TherapiesMaëlle Lorvellec, Alessandro Filippo Pellegata, Alice Maestri, et al.
Gene Therapy|January 11, 2023
Preclinical evaluation of FLT190, a liver-directed AAV gene therapy for Fabry diseaseJey M Jeyakumar, Azadeh Kia, Lawrence C S Tam, et al.
Journal of Hepatology|January 14, 2017
Vps33b is crucial for structural and functional hepatocyte polarityJoanna Hanley, Dipok Kumar Dhar, Francesca Mazzacuva, et al.
Acta Neuropathologica Communications|September 8, 2022
Mitochondrial dysfunction is a key pathological driver of early stage Parkinson'sChristina E Toomey, Wendy E Heywood, James R Evans, et al.
Pageof 13

Showing results (101-110 of 129) with videos related to

Sort By:
Pageof 13
Analytical Chemistry|November 6, 2015
Proteomic Discovery and Development of a Multiplexed Targeted MRM-LC-MS/MS Assay for Urine Biomarkers of Extracellular Matrix Disruption in Mucopolysaccharidoses I, II, and VIWendy E Heywood, Stephane Camuzeaux, Ivan Doykov, et al.
Brain, Behavior, and Immunity|December 13, 2025
Resistant starch improves Parkinson's disease symptoms through restructuring of the gut microbiome and modulating inflammationViacheslav A Petrov, Sebastian Schade, Cedric C Laczny, et al.
Scientific Reports|June 22, 2016
The embryological basis of subclinical hypertrophic cardiomyopathyGabriella Captur, Carolyn Y Ho, Saskia Schlossarek, et al.
JAMA Neurology|January 14, 2020
Ambroxol for the Treatment of Patients With Parkinson Disease With and Without Glucocerebrosidase Gene Mutations: A Nonrandomized, Noncontrolled TrialStephen Mullin, Laura Smith, Katherine Lee, et al.
International Journal of Molecular Sciences|January 21, 2022
Tissue Proteome of 2-Hydroxyacyl-CoA Lyase Deficient Mice Reveals Peroxisome Proliferation and Activation of ω-OxidationYoussef Khalil, Sara Carrino, Fujun Lin, et al.
Molecular Neurodegeneration|February 25, 2016
Erratum to: Identification of novel CSF biomarkers for neurodegeneration and their validation by a high-throughput multiplexed targeted proteomic assayWendy E Heywood, Daniela Galimberti, Emily Bliss, et al.
Iscience|December 11, 2020
An <i>In Vitro</i> Whole-Organ Liver Engineering for Testing of Genetic TherapiesMaëlle Lorvellec, Alessandro Filippo Pellegata, Alice Maestri, et al.
Gene Therapy|January 11, 2023
Preclinical evaluation of FLT190, a liver-directed AAV gene therapy for Fabry diseaseJey M Jeyakumar, Azadeh Kia, Lawrence C S Tam, et al.
Journal of Hepatology|January 14, 2017
Vps33b is crucial for structural and functional hepatocyte polarityJoanna Hanley, Dipok Kumar Dhar, Francesca Mazzacuva, et al.
Acta Neuropathologica Communications|September 8, 2022
Mitochondrial dysfunction is a key pathological driver of early stage Parkinson'sChristina E Toomey, Wendy E Heywood, James R Evans, et al.
Pageof 13